NA
Nibha Atul Shrivastav
About Nibha Atul Shrivastav
Data last updated:
Nibha Atul Shrivastav is a Director at Swastik Pharmaceuticals Private Limited (since 2022). The company operates in Business Outsourcing. Swastik Pharmaceuticals Private Limited reported revenue of ₹87.6 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Swastik Pharmaceuticals Private Limited U51909UP2022PTC166276 | Director | 22 Jun 2022 | 2022 | ₹87.6 Lakh (FY 2023) | Active |
Board colleagues of Nibha Atul Shrivastav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ram Nivas Srivastav | 09648660 | Swastik Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nibha Atul Shrivastav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nibha Atul Shrivastav
Nibha Atul Shrivastav currently holds 1 directorship: Swastik Pharmaceuticals Private Limited (Director, since 22 Jun 2022, revenue ₹87.6 Lakh (FY 2023)).
Nibha Atul Shrivastav was first appointed on 22 Jun 2022 as Director at Swastik Pharmaceuticals Private Limited.
The current boards of Nibha Atul Shrivastav's companies include Ram Nivas Srivastav (Swastik Pharmaceuticals Private Limited).